| 前收盘价格 | 0.540 |
| 收盘价格 | 0.520 |
| 成交量 | 159,717 |
| 平均成交量 (3个月) | 66,009 |
| 市值 | 118,304,960 |
| 预期市盈率 (P/E Forward) | 31.75 |
| 价格/销量 (P/S) | 0.980 |
| 股市价格/股市净资产 (P/B) | 2.36 |
| 52周波幅 |
| 营业毛利率 | -5.98% |
| 营业利益率 (TTM) | 2.63% |
| 稀释每股收益 (EPS TTM) | -0.050 |
| 季度收入增长率 (YOY) | 19.10% |
| 总债务/股东权益 (D/E MRQ) | 12.45% |
| 流动比率 (MRQ) | 1.81 |
| 营业现金流 (OCF TTM) | 2.32 M |
| 杠杆自由现金流 (LFCF TTM) | -6.86 M |
| 资产报酬率 (ROA TTM) | -2.14% |
| 股东权益报酬率 (ROE TTM) | -15.51% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (AU) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | SOMNOMED FPO [SOM] | - | - |
AIStockmoo 评分
0.3
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.25 |
|
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 20.13% |
| 机构持股比例 | 57.68% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合